Does Metformin Reduce Cancer Risk? The VA Weighs In
Over the last decade, a number of studies have examined a possible association between metformin use and reduction in the risk of cancer, with contradictory results.
Over the last decade, a number of studies have examined a possible association between metformin use and reduction in the risk of cancer, with contradictory results.
For years, chemotherapy provided the only hope for patients with chronic lymphocytic leukemia (CLL).
In the case of chronic lymphocytic leukemia (CLL) with prolymphocytic progression, a newly defined and very rare type of cancer, the scale of the VA and the number of patients it treats with leukemia allowed VA researchers to describe the characteristics and progression of the disease and begin to understand how it responds to current therapies.
Now that the first major provisions of the PACT Act went into effect at the beginning of last month, what happens next?